Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder.

Whalley HC, Papmeyer M, Romaniuk L, Sprooten E, Johnstone EC, Hall J, Lawrie SM, Evans KL, Blumberg HP, Sussmann JE, McIntosh AM.

Neuropsychopharmacology. 2012 Nov;37(12):2720-9. doi: 10.1038/npp.2012.137. Epub 2012 Aug 1.

2.

The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia.

Kuswanto CN, Sum MY, Qiu A, Sitoh YY, Liu J, Sim K.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jul;168B(5):317-26. doi: 10.1002/ajmg.b.32314. Epub 2015 Apr 29.

PMID:
25921703
3.

Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation.

van Erp TG, Guella I, Vawter MP, Turner J, Brown GG, McCarthy G, Greve DN, Glover GH, Calhoun VD, Lim KO, Bustillo JR, Belger A, Ford JM, Mathalon DH, Diaz M, Preda A, Nguyen D, Macciardi F, Potkin SG.

Biol Psychiatry. 2014 Mar 1;75(5):398-405. doi: 10.1016/j.biopsych.2013.06.016. Epub 2013 Aug 1.

4.

The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.

Chakirova G, Whalley HC, Thomson PA, Hennah W, Moorhead TW, Welch KA, Giles S, Hall J, Johnstone EC, Lawrie SM, Porteous DJ, Brown VJ, McIntosh AM.

Psychiatry Res. 2011 Apr 30;192(1):20-8. doi: 10.1016/j.pscychresns.2011.01.015. Epub 2011 Mar 3.

PMID:
21376542
5.

Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls.

Papagni SA, Mechelli A, Prata DP, Kambeitz J, Fu CH, Picchioni M, Walshe M, Toulopoulou T, Bramon E, Murray RM, Collier DA, Bellomo A, McGuire P.

Neuroimage. 2011 Jun 15;56(4):2283-91. doi: 10.1016/j.neuroimage.2011.03.037. Epub 2011 Mar 21.

PMID:
21421061
6.

Effects of a mis-sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia.

Whalley HC, Sussmann JE, Johnstone M, Romaniuk L, Redpath H, Chakirova G, Mukherjee P, Hall J, Johnstone EC, Lawrie SM, McIntosh AM.

Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):343-53. doi: 10.1002/ajmg.b.32035. Epub 2012 Feb 15.

PMID:
22337479
7.

The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder.

Mechelli A, Prata DP, Fu CH, Picchioni M, Kane F, Kalidindi S, McDonald C, Demjaha A, Kravariti E, Toulopoulou T, Murray R, Collier DA, McGuire PK.

Neuroimage. 2008 Aug 15;42(2):817-26. doi: 10.1016/j.neuroimage.2008.05.025. Epub 2008 May 27.

PMID:
18585932
8.

Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia.

Kuswanto CN, Woon PS, Zheng XB, Qiu A, Sitoh YY, Chan YH, Liu J, Williams H, Ong WY, Sim K.

Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):255-62. doi: 10.1002/ajmg.b.32032. Epub 2012 Feb 10.

PMID:
22328493
9.

Effects of MIR137 on fronto-amygdala functional connectivity.

Mothersill O, Morris DW, Kelly S, Rose EJ, Fahey C, O'Brien C, Lyne R, Reilly R, Gill M, Corvin AP, Donohoe G.

Neuroimage. 2014 Apr 15;90:189-95. doi: 10.1016/j.neuroimage.2013.12.019. Epub 2013 Dec 19.

PMID:
24361663
10.

Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia.

Whalley HC, Gountouna VE, Hall J, McIntosh A, Whyte MC, Simonotto E, Job DE, Owens DG, Johnstone EC, Lawrie SM.

BMC Psychiatry. 2007 Oct 29;7:61.

11.

The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects.

Liu B, Zhang X, Hou B, Li J, Qiu C, Qin W, Yu C, Jiang T.

Neuropsychopharmacology. 2014 Aug;39(9):2153-60. doi: 10.1038/npp.2014.63. Epub 2014 Mar 14.

13.

fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia.

Whalley HC, Gountouna VE, Hall J, McIntosh AM, Simonotto E, Job DE, Owens DG, Johnstone EC, Lawrie SM.

Psychol Med. 2009 Jul;39(7):1189-99. doi: 10.1017/S0033291708004923. Epub 2008 Dec 24.

PMID:
19105855
14.

A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder.

Duan J, Shi J, Fiorentino A, Leites C, Chen X, Moy W, Chen J, Alexandrov BS, Usheva A, He D, Freda J, O'Brien NL; Molecular Genetics of Schizophrenia collaboration.; Genomic Psychiatric Cohort consortium., McQuillin A, Sanders AR, Gershon ES, DeLisi LE, Bishop AR, Gurling HM, Pato MT, Levinson DF, Kendler KS, Pato CN, Gejman PV.

Am J Hum Genet. 2014 Dec 4;95(6):744-53. doi: 10.1016/j.ajhg.2014.11.001. Epub 2014 Nov 26.

15.

Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.

Williams NM, Green EK, Macgregor S, Dwyer S, Norton N, Williams H, Raybould R, Grozeva D, Hamshere M, Zammit S, Jones L, Cardno A, Kirov G, Jones I, O'Donovan MC, Owen MJ, Craddock N.

Arch Gen Psychiatry. 2006 Apr;63(4):366-73.

PMID:
16585465
16.

Enuresis as a premorbid developmental marker of schizophrenia.

Hyde TM, Deep-Soboslay A, Iglesias B, Callicott JH, Gold JM, Meyer-Lindenberg A, Honea RA, Bigelow LB, Egan MF, Emsellem EM, Weinberger DR.

Brain. 2008 Sep;131(Pt 9):2489-98. doi: 10.1093/brain/awn167. Epub 2008 Jul 31.

17.

The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives.

Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P, Powell J, Collier DA, Frangou S.

Psychol Med. 2011 Apr;41(4):779-88. doi: 10.1017/S0033291710001431. Epub 2010 Jul 29.

PMID:
20667170
18.

Association between genetic risk scoring for schizophrenia and bipolar disorder with regional subcortical volumes.

Caseras X, Tansey KE, Foley S, Linden D.

Transl Psychiatry. 2015 Dec 8;5:e692. doi: 10.1038/tp.2015.195.

19.

A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects.

Raum H, Dietsche B, Nagels A, Witt SH, Rietschel M, Kircher T, Krug A.

Hum Brain Mapp. 2015 Jan;36(1):378-90. doi: 10.1002/hbm.22635. Epub 2014 Sep 13.

PMID:
25220293
20.

Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity.

Paulus FM, Bedenbender J, Krach S, Pyka M, Krug A, Sommer J, Mette M, Nöthen MM, Witt SH, Rietschel M, Kircher T, Jansen A.

Hum Brain Mapp. 2014 Apr;35(4):1190-200. doi: 10.1002/hbm.22244. Epub 2013 Feb 13.

PMID:
23404764

Supplemental Content

Support Center